Psyched Wellness Submits an Application to Register a Trademark for the Company’s Unique Extraction
Toronto, Ontario – January 21, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has submitted an application with the United States Patent and Trademark Office (USPTO) to register […]
Psyched Wellness Announces New OTCQB Ticker: PSYCF
Toronto, Ontario- January 19, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (formerly Duncan Park Holdings Corporation) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that FINRA accepted its proposed symbol change for the OTCQB market from […]
Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol
Toronto, Ontario – January 14, 2021 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has completed the first step in identifying the medicinal potential of […]
Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol
Toronto, Ontario – January 6, 2021 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has commenced a study to determine the therapeutic values of muscimol […]